Status:
COMPLETED
Retrospective Evaluation of a Commercially Available Hydrogel Spacer (BP-009)
Lead Sponsor:
BioProtect
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
Dosimetry efficacy of the hydrogel spacer.
Detailed Description
Single arm study for evaluation of dosimetry following use of a commercially available hydrogel spacer implanted in up to 20 males who underwent radiotherapy treatment for prostate cancer. Study utili...
Eligibility Criteria
Inclusion
- Males
- At least 18 years of age
- Undergone external beam or brachy radiation therapy with a hydrogel spacer in place
Exclusion
- Clinical and pathological data are not available
- Invasive adenocarcinoma that is extracapsular and demonstrates posterior extension
Key Trial Info
Start Date :
November 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT05423431
Start Date
November 9 2020
End Date
June 30 2021
Last Update
June 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Advanced Radiation Centers of New York ("ARC")
Lake Success, New York, United States, 111042